• Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

    Source: Nasdaq GlobeNewswire / 07 Feb 2024 08:00:00   America/New_York

    CAMBRIDGE, Mass., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host virtual 1x1 investor meetings at the Oppenheimer 34th Annual Healthcare Life Sciences Conference.

    Oppenheimer 34th Annual Healthcare Life Sciences Conference
    Fireside Chat: Wednesday, February 14, 2024 at 10:00 am ET
    Location: Virtual

    A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com.

    About Vor Bio
    Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

    Contact:

    Media & Investors
    Sarah Spencer
    +1 857-242-6076
    sspencer@vorbio.com


    Primary Logo

Share on,